Joanne M. Donovan

Chief Tech/Sci/R&D Officer presso EDGEWISE THERAPEUTICS, INC.

Patrimonio netto: 181 670 $ in data 31/03/2024

67 anni

100 relazioni

Health Technology

Finance

Consumer Services

Profilo

Joanne M.
Donovan is currently the Chief Medical Officer at Edgewise Therapeutics, Inc. She previously worked as the Vice President-Clinical Development at Genzyme Corp.
from 1998 to 2011, and as the Chief Medical Officer & SVP-Clinical Development at Astria Therapeutics, Inc. from 2011 to 2021.
Prior to that, she worked as the Medical Director at GelTex Pharmaceuticals, Inc. and as an Associate Clinical Professor at Harvard Medical School.
Donovan holds a doctorate degree from both Massachusetts Institute of Technology and Harvard Medical School.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
EDGEWISE THERAPEUTICS, INC. 0.01%	17/08/2023	9 960 ( 0.01% )	181 670 $	31/03/2024

Posizioni attive di Joanne M. Donovan

Società	Posizione	Inizio
EDGEWISE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	27/04/2021

Tutte le posizioni attive di Joanne M. Donovan

Precedenti posizioni note di Joanne M. Donovan

Società	Posizione	Fine
ASTRIA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	23/04/2021
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Chief Tech/Sci/R&D Officer	01/01/2011
Harvard Medical School	Corporate Officer/Principal	-
GelTex Pharmaceuticals, Inc. GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA.	Chief Tech/Sci/R&D Officer	-

Vedi nel dettaglio l'esperienza di Joanne M. Donovan

Formazione di Joanne M. Donovan

Massachusetts Institute of Technology	Doctorate Degree
Harvard Medical School	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Joanne M. Donovan

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ASTRIA THERAPEUTICS, INC.	Health Technology
EDGEWISE THERAPEUTICS, INC.	Health Technology

Aziende private	2
GelTex Pharmaceuticals, Inc. GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA.	Health Technology
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology